Correlation Between Cue Biopharma and Revelation Biosciences

Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cue Biopharma and Revelation Biosciences, you can compare the effects of market volatilities on Cue Biopharma and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Revelation Biosciences.

Diversification Opportunities for Cue Biopharma and Revelation Biosciences

-0.16

Correlation Coefficient

Cue Biopharma  Revelation Biosciences

Good diversification

The 3 months correlation between Cue and Revelation is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Revelation Biosciences go up and down completely randomly.

Pair Corralation between Cue Biopharma and Revelation Biosciences

Considering the 90-day investment horizon Cue Biopharma is expected to generate 1.37 times more return on investment than Revelation Biosciences. However, Cue Biopharma is 1.37 times more volatile than Revelation Biosciences. It trades about 0.13 of its potential returns per unit of risk. Revelation Biosciences is currently generating about 0.02 per unit of risk. If you would invest  66.00  in Cue Biopharma on August 31, 2024 and sell it today you would earn a total of  56.00  from holding Cue Biopharma or generate 84.85% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Cue Biopharma  vs.  Revelation Biosciences

Cue Biopharma

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cue Biopharma are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Cue Biopharma exhibited solid returns over the last few months and may actually be approaching a breakup point.

Revelation Biosciences

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Revelation Biosciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady fundamental drivers, Revelation Biosciences may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Pair Trading with Cue Biopharma and Revelation Biosciences

The main advantage of trading using opposite Cue Biopharma and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.

The idea behind Cue Biopharma and Revelation Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.